Company Filing History:
Years Active: 2015-2019
Title: Innovator Ammen P. Dhillon: Pioneering Therapeutic Approaches
Introduction
Ammen P. Dhillon, hailing from Delta, CA, is an accomplished inventor known for his significant contributions to the field of therapeutic innovations. With a focus on developing methods to combat viral infections and address serious medical conditions, Dhillon holds two patents that reflect his commitment to advancing healthcare solutions.
Latest Patents
His recent inventions include two notable patents:
1. **Compositions and methods for silencing hepatitis B virus gene expression**: This invention comprises therapeutic nucleic acids, such as small interfering RNA (siRNA), designed to target Hepatitis B virus (HBV) gene expression. The patent outlines lipid particles that incorporate these nucleic acids, along with methods for their delivery and administration aimed at treating HBV and HDV infections in humans.
2. **Compositions and methods for silencing SMAD4**: This invention revolves around therapeutic nucleic acids that target SMAD4 gene expression. The patent includes the creation of lipid particles containing these nucleic acids and methods for their delivery, intended to treat anemia of inflammation in humans.
Career Highlights
Ammen Dhillon has had an impactful career, working with prominent companies in the biotherapeutics industry. Notable organizations he has contributed to include Protiva Biotherapeutics, Inc. and Arbutus Biopharma Corporation. These experiences have provided him with a robust foundation for his innovation in therapeutic applications.
Collaborations
Throughout his career, Dhillon has collaborated with esteemed professionals, including Amy C. H. Lee and Ian MacLachlan. These collaborations have fostered a productive environment for brainstorming and developing groundbreaking therapeutic solutions.
Conclusion
Ammen P. Dhillon stands as a remarkable inventor whose work continues to influence the landscape of medical therapies. His contributions, particularly in targeting challenging viral infections and genetic expressions, exemplify the power of innovation in healthcare. With ongoing research and development, Dhillon’s future work promises to further enhance therapeutic possibilities and improve patient outcomes.